| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 31.22B | 30.85B | 28.03B | 29.22B | 28.16B | 25.94B |
| Gross Profit | 8.24B | 8.14B | 6.95B | 7.92B | 8.07B | 7.21B |
| EBITDA | 3.58B | 3.62B | 2.62B | 3.75B | 4.15B | 2.84B |
| Net Income | 1.49B | 1.69B | 1.08B | 1.92B | 2.16B | 1.13B |
Balance Sheet | ||||||
| Total Assets | 33.79B | 34.22B | 32.74B | 31.35B | 31.40B | 29.43B |
| Cash, Cash Equivalents and Short-Term Investments | 4.62B | 5.85B | 5.16B | 5.74B | 5.35B | 5.02B |
| Total Debt | 171.13M | 180.61M | 276.86M | 360.55M | 671.24M | 1.03B |
| Total Liabilities | 8.71B | 9.06B | 8.79B | 8.00B | 8.56B | 7.95B |
| Stockholders Equity | 25.08B | 25.16B | 23.95B | 23.36B | 22.40B | 21.09B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 1.45B | 382.15M | -248.79M | 1.81B | 1.70B |
| Operating Cash Flow | 0.00 | 3.34B | 2.48B | 1.30B | 2.60B | 2.89B |
| Investing Cash Flow | 0.00 | -2.14B | -2.10B | 1.02B | -766.54M | -1.19B |
| Financing Cash Flow | 0.00 | -504.08M | -1.04B | -1.97B | -1.57B | -1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
79 Outperform | ¥19.08B | 12.32 | ― | 2.62% | 8.18% | -4.59% | |
79 Outperform | ¥549.06B | 13.65 | 6.55% | 2.71% | -0.06% | 137.47% | |
76 Outperform | ¥78.67B | 12.49 | ― | 6.64% | 2.85% | -9.13% | |
73 Outperform | ¥86.92B | 13.19 | ― | 3.31% | 0.83% | -9.16% | |
70 Outperform | ¥157.69B | 7.06 | 10.46% | 2.35% | 4.56% | 49.23% | |
70 Outperform | ¥19.56B | 13.58 | ― | 4.39% | 5.06% | -15.22% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% |